{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T13:22:13Z","timestamp":1774531333179,"version":"3.50.1"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Hypotheses"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.mehy.2021.110645","type":"journal-article","created":{"date-parts":[[2021,7,19]],"date-time":"2021-07-19T17:51:32Z","timestamp":1626717092000},"page":"110645","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["On the prevention and treatment of Alzheimer\u2019s disease: Control the promoters and look beyond the brain"],"prefix":"10.1016","volume":"154","author":[{"given":"Mark R.","family":"Goldstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Cheslock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mehy.2021.110645_b0005","doi-asserted-by":"crossref","unstructured":"Alzheimer\u2019s Association. 2019 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 2019;321-387. 10.1016\/j.jalz.2019.01.010.","DOI":"10.1016\/j.jalz.2019.01.010"},{"issue":"16","key":"10.1016\/j.mehy.2021.110645_b0010","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1001\/jama.2019.4782","article-title":"Diagnosis and management of dementia: review","volume":"322","author":"Arvanitakis","year":"2019","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mehy.2021.110645_b0015","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"issue":"10","key":"10.1016\/j.mehy.2021.110645_b0020","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/jamaneurol.2019.1971","article-title":"Prevalence of biologically vs clinically defined Alzheimer spectrum entities using the national institute on aging-Alzheimer\u2019s association research framework","volume":"76","author":"Jack","year":"2019","journal-title":"JAMA Neurol"},{"issue":"7","key":"10.1016\/j.mehy.2021.110645_b0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/nan.12642","article-title":"Invited review \u2013 Understanding cause and effect in Alzheimer\u2019s pathophysiology: implications for clinical trials","volume":"46","author":"Boche","year":"2020","journal-title":"Neuropathol. Appl. Neurobiol."},{"issue":"3","key":"10.1016\/j.mehy.2021.110645_b0030","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41582-018-0132-6","article-title":"Dementia in down syndrome: unique insights for Alzheimer disease research","volume":"15","author":"Lott","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"10.1016\/j.mehy.2021.110645_b0035","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1002\/alz.12112","article-title":"Further understanding the connection between Alzheimer\u2019s disease and Down syndrome","volume":"16","author":"Snyder","year":"2020","journal-title":"Alzheimer\u2019s Dement"},{"issue":"9","key":"10.1016\/j.mehy.2021.110645_b0040","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41582-019-0228-7","article-title":"Apolipoprotein E and Alzheimer disease; pathobiology and targeting strategies","volume":"15","author":"Yamazaki","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.mehy.2021.110645_b0045","doi-asserted-by":"crossref","first-page":"e1745","DOI":"10.1212\/WNL.0000000000007231","article-title":"Relative risk for Alzheimer disease based on complete family history","volume":"92","author":"Cannon-Albright","year":"2019","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.mehy.2021.110645_b0050","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1016\/j.neuron.2019.01.056","article-title":"A quarter century of APOE and Alzheimer\u2019s disease: Progress to date and the path forward","volume":"101","author":"Belloy","year":"2019","journal-title":"Neuron"},{"key":"10.1016\/j.mehy.2021.110645_b0055","doi-asserted-by":"crossref","unstructured":"Gale SC, Gao l, Mikacenic C, et al. APOe4 is associated with enhanced in vivo innate immune responses in human subjects. J Allergy Clin Immunol 2014;134(1):127-134. 10.1016\/j.jaci.2014.01.032.","DOI":"10.1016\/j.jaci.2014.01.032"},{"issue":"9","key":"10.1016\/j.mehy.2021.110645_b0060","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13195-014-0082-1","article-title":"Prevalence of mixed pathologies in the aging brain","volume":"6","author":"Rahimi","year":"2014","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.mehy.2021.110645_b0065","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jalz.2018.07.222","article-title":"Vascular dysfunction \u2013 The disregarded partner of Alzheimer\u2019s disease","volume":"15","author":"Sweeney","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.mehy.2021.110645_b0070","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3233\/JAD-190507","article-title":"Developing effective Alzheimer\u2019s disease therapies; Clinical experience and future directions","volume":"71","author":"Elmaleh","year":"2019","journal-title":"J Alzheimers Dis"},{"issue":"10","key":"10.1016\/j.mehy.2021.110645_b0075","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/nrneurol.2017.111","article-title":"A systemic view of Alzheimer disease \u2013 insights from amyloid-\u00df metabolism beyond the brain","volume":"13","author":"Wang","year":"2017","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.mehy.2021.110645_b0080","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/s41582-019-0281-2","article-title":"Cerebral amyloid angiopathy and Alzheimer disease \u2013 one peptide, two pathways","volume":"16","author":"Greenberg","year":"2020","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.mehy.2021.110645_b0085","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000505625","article-title":"An integrated view on vascular dysfunction in Alzheimer\u2019s disease","volume":"19","author":"Klohs","year":"2019","journal-title":"Neurodegener Dis"},{"issue":"4","key":"10.1016\/j.mehy.2021.110645_b0090","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00401-020-02196-w","article-title":"The physiological roles of tau and A\u00df: implications for Alzheimer\u2019s disease pathology and therapeutics","volume":"140","author":"Kent","year":"2020","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.mehy.2021.110645_b0095","doi-asserted-by":"crossref","first-page":"3948360","DOI":"10.1155\/2017\/3948360","article-title":"A\u00df peptide originated from platelets promises new strategy in anti-Alzheimer\u2019s drug development","volume":"2017","author":"Inyushin","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.mehy.2021.110645_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.nbd.2020.104784","article-title":"APOE-amyloid interaction: therapeutic targets","volume":"138","author":"Wisniewski","year":"2020","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.mehy.2021.110645_b0105","first-page":"575","article-title":"Inflammation as a central mechanism in Alzheimer\u2019s disease","volume":"4","author":"Kinney","year":"2018","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.mehy.2021.110645_b0110","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/s41582-020-00435-y","article-title":"Neuroinflammation and microglial activation in Alzheimer disease: where do we go from here?","volume":"17","author":"Leng","year":"2021","journal-title":"Nat Rev Neurol"},{"issue":"6301","key":"10.1016\/j.mehy.2021.110645_b0115","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.mehy.2021.110645_b0120","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/s41577-018-0051-1","article-title":"Interplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight","volume":"18","author":"Shi","year":"2018","journal-title":"Nat Rev Immunol"},{"issue":"11","key":"10.1016\/j.mehy.2021.110645_b0125","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1038\/s41582-018-0072-1","article-title":"TREM2 \u2013 a key player in microglial biology and Alzheimer disease","volume":"14","author":"Ulland","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"7784","key":"10.1016\/j.mehy.2021.110645_b0130","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41586-019-1769-z","article-title":"NLRP3 inflammasome activation drives tau pathology","volume":"575","author":"Ising","year":"2019","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.mehy.2021.110645_b0135","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.bj.2018.01.003","article-title":"Tau and neuroinflammation: what impact for Alzheimer\u2019s disease and Tauopathies?","volume":"41","author":"Laurent","year":"2018","journal-title":"Biomed J"},{"issue":"1","key":"10.1016\/j.mehy.2021.110645_b0140","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1186\/s40478-019-0754-y","article-title":"intersection of pathological tau and microglia at the synapse","volume":"7","author":"Vogels","year":"2019","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"10.1016\/j.mehy.2021.110645_b0145","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.3597","article-title":"Association of chronic low-grade inflammation with risk of Alzheimer disease in ApoE4 carriers","volume":"1","author":"Tao","year":"2018","journal-title":"JAMA Netw Open"},{"issue":"4","key":"10.1016\/j.mehy.2021.110645_b0150","doi-asserted-by":"crossref","first-page":"979","DOI":"10.3233\/JAD-160152","article-title":"Microbes and Alzheimer\u2019s disease","volume":"51","author":"Itzhaki","year":"2016","journal-title":"J Alzheimers Dis"},{"issue":"9","key":"10.1016\/j.mehy.2021.110645_b0155","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1080\/14787210.2019.1656064","article-title":"Herpes simplex virus type 1 and Alzheimer\u2019s disease: link and potential impact on treatment","volume":"17","author":"Mancuso","year":"2019","journal-title":"Expert Rev Anti Infect Ther"},{"issue":"7","key":"10.1016\/j.mehy.2021.110645_b0160","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2174\/1570159X15666170313122937","article-title":"The infectious etiology of Alzheimer\u2019s disease","volume":"15","author":"Sochocka","year":"2017","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.mehy.2021.110645_b0165","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.bbi.2019.07.002","article-title":"Systemic inflammation linking chronic periodontitis to cognitive decline","volume":"81","author":"Wang","year":"2019","journal-title":"Brain Behav Immun"},{"issue":"4","key":"10.1016\/j.mehy.2021.110645_b0170","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jalz.2018.12.005","article-title":"Hospitalization, surgery, and incident dementia","volume":"15","author":"Eriksson","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.mehy.2021.110645_b0175","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ebiom.2018.10.021","article-title":"Surgery, neuroinflammation and cognitive impairment","volume":"37","author":"Alam","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mehy.2021.110645_b0180","doi-asserted-by":"crossref","first-page":"7177","DOI":"10.1038\/s41598-019-42351-2","article-title":"Observational study of long-term persistant elevation of neurodegeneration markers after cardiac surgery","volume":"9","author":"DiMeglio","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.mehy.2021.110645_b0185","doi-asserted-by":"crossref","unstructured":"Greaves D, Psaltis PJ, Davis DHJ, et al. Risk factors for delirium and cognitive decline following coronary artery bypass grafting surgery: A systematic review and meta-analysis. J Am Heart Assoc 2020;9(22):e017275. Published online 2020 Nov 7. 10.1161\/JAHA.120.017275.","DOI":"10.1161\/JAHA.120.017275"},{"issue":"1","key":"10.1016\/j.mehy.2021.110645_b0190","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/s41572-020-00223-4","article-title":"Delirium","volume":"6","author":"Wilson","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"6","key":"10.1016\/j.mehy.2021.110645_b0195","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJMoa1215740","article-title":"Glucose levels and risk of dementia","volume":"369","author":"Crane","year":"2013","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.mehy.2021.110645_b0200","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.bbadis.2016.04.017","article-title":"Common neurodegenerative pathways in obesity, diabetes, and Alzheimer\u2019s disease","volume":"1863","author":"Pugazhenthi","year":"2017","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"issue":"Suppl 2","key":"10.1016\/j.mehy.2021.110645_b0205","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1016\/j.neurobiolaging.2014.03.035","article-title":"Amyloid-\u00df diurnal pattern: possible role of sleep in Alzheimer\u2019s disease pathogenesis","volume":"35","author":"Lucey","year":"2014","journal-title":"Neurobiol Aging"},{"issue":"11","key":"10.1016\/j.mehy.2021.110645_b0210","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/s41577-019-0190-z","article-title":"Sleep and inflammation: partners in sickness and in health","volume":"19","author":"Irwin","year":"2019","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.mehy.2021.110645_b0215","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.100966","article-title":"Is Alzheimer\u2019s disease an inflammasomopathy?","volume":"56","author":"Pereira","year":"2019","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.mehy.2021.110645_b0220","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12974-020-01877-3","article-title":"Myeloproliferative blood cancers as a human neuroinflammation model for development of Alzheimer\u2019s disease: evidences and perspectives","volume":"17","author":"Hasselbalch","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"2","key":"10.1016\/j.mehy.2021.110645_b0225","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090523","article-title":"Blood platelets in the progression of Alzheimer\u2019s disease","volume":"9","author":"Gowert","year":"2014","journal-title":"PLoS ONE"},{"issue":"11","key":"10.1016\/j.mehy.2021.110645_b0230","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1038\/jcbfm.2010.140","article-title":"Predictive value of platelet activation for the rate of cognitive decline in Alzheimer\u2019s disease patients","volume":"30","author":"Stellos","year":"2010","journal-title":"J Cereb Blood Flow Metab"},{"issue":"2","key":"10.1016\/j.mehy.2021.110645_b0235","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCRESAHA.117.310795","article-title":"Circulating platelets as mediators of immunity, inflammation, and thrombosis","volume":"122","author":"Koupenova","year":"2018","journal-title":"Circ Res"},{"issue":"2","key":"10.1016\/j.mehy.2021.110645_b0240","first-page":"151","article-title":"Alcohol and Alzheimer\u2019s disease \u2013 Does alcohol dependence contribute to beta-amyloid deposition, neuroinflammation and neurodegeneration in Alzheimer\u2019s disease?","volume":"52","author":"Venkataraman","year":"2017","journal-title":"Alcohol Alcohol"},{"issue":"4","key":"10.1016\/j.mehy.2021.110645_b0245","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1001\/jamaneurol.2019.4828","article-title":"Associations of apolipoprotein E e4 genotype and ball heading with verbal memory in amateur soccer players","volume":"77","author":"Hunter","year":"2020","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.mehy.2021.110645_b0250","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.bbi.2019.11.006","article-title":"Mold inhalation causes innate immune activation, neural, cognitive and emotional dysfunction","volume":"87","author":"Harding","year":"2020","journal-title":"Brain Behav Immun"},{"issue":"1","key":"10.1016\/j.mehy.2021.110645_b0255","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2016.280","article-title":"Particulate air pollutants, APOE alleles and their contributions to cognitive impairment in older women and to amyloidogenesis in experimental models","volume":"7","author":"Cacciottolo","year":"2017","journal-title":"Transl psychiatry"},{"issue":"3","key":"10.1016\/j.mehy.2021.110645_b0260","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1017\/S0317167100044115","article-title":"Limbic predilection in Alzheimer dementia: is reactivated herpesvirus involved?","volume":"9","author":"Ball","year":"1982","journal-title":"Can J Neurol Sci"},{"key":"10.1016\/j.mehy.2021.110645_b0265","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1086\/590213","article-title":"Susceptibility to herpes simplex labialis conferred by the gene encoding apolipoprotein E","volume":"198","author":"Itzhaki","year":"2008","journal-title":"J Infec Dis"},{"issue":"1","key":"10.1016\/j.mehy.2021.110645_b0270","doi-asserted-by":"crossref","first-page":"211","DOI":"10.3233\/JAD-171162","article-title":"Herpes simplex virus, APOE e4, and cognitive decline in old age: results from the Betula Cohort Study","volume":"67","author":"L\u00f6vheim","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/j.mehy.2021.110645_b0275","first-page":"697","article-title":"A genetic signature including apolipoprotein Ee4 potentiates the risk of herpes simplex-associated Alzheimer\u2019s disease","volume":"5","author":"Lindman","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"1","key":"10.1016\/j.mehy.2021.110645_b0280","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/alz.12008","article-title":"Interaction between APOE4 and herpes simplex virus type 1 in Alzheimer\u2019s disease","volume":"16","author":"Linard","year":"2020","journal-title":"Alzheimers Dement"},{"issue":"3","key":"10.1016\/j.mehy.2021.110645_b0285","article-title":"Recurrent herpes simplex virus-1 infection induces hallmarks of neurodegeneration and cognitive deficits in mice","volume":"15","author":"De Charia","year":"2019","journal-title":"PLoS Pathog"},{"issue":"2","key":"10.1016\/j.mehy.2021.110645_b0290","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s13311-018-0611-x","article-title":"Anti-herpetic medications and reduced risk of dementia in patients with herpes simplex virus infections \u2013 a nationwide, population-based cohort study in Taiwan","volume":"15","author":"Tzeng","year":"2018","journal-title":"Neurotherapeutics"},{"issue":"10","key":"10.1016\/j.mehy.2021.110645_b0295","first-page":"2905","article-title":"Time to test antibacterial therapy in Alzheimer\u2019s disease","volume":"142","author":"Panza","year":"2019","journal-title":"Brain"},{"issue":"11","key":"10.1016\/j.mehy.2021.110645_b0300","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/archinte.168.11.1137","article-title":"The treatment of herpes simplex infections: an evidenced-based review","volume":"168","author":"Cernik","year":"2008","journal-title":"Arch Intern Med"},{"issue":"11","key":"10.1016\/j.mehy.2021.110645_b0305","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0188490","article-title":"Increased risk of dementia following herpes zoster ophthalmicus","volume":"12","author":"Tsai","year":"2017","journal-title":"PLoS ONE"},{"key":"10.1016\/j.mehy.2021.110645_b0310","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2019.100956","article-title":"Olfactory dysfunction in the pathophysiological continuum of dementia","volume":"55","author":"Bathini","year":"2019","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.mehy.2021.110645_b0315","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.neuron.2018.05.023","article-title":"Multiscale analysis of independent Alzheimer\u2019s cohorts finds disruption of molecular, genetic, and clinical networks by human herpesvirus","volume":"99","author":"Readhead","year":"2018","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.mehy.2021.110645_b0320","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.neuron.2018.06.030","article-title":"Alzheimer\u2019s disease-associated \u00df-amyloid is rapidly seeded by Herpesviridae to protect against brain infection","volume":"99","author":"Eimer","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/j.mehy.2021.110645_b0325","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032112","article-title":"Antiviral therapy: Valacyclovir Treatment of Alzheimer\u2019s Disease (VALAD) Trial: protocol for a randomised, double-blind, placebo-controlled, treatment trial","volume":"10","author":"Devanand","year":"2020","journal-title":"BMJ Open"},{"issue":"3","key":"10.1016\/j.mehy.2021.110645_b0330","doi-asserted-by":"crossref","first-page":"725","DOI":"10.3233\/JAD-141170","article-title":"The microbiome and disease: reviewing the links between the oral microbiome, aging, and Alzheimer\u2019s disease","volume":"43","author":"Shoemark","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"2","key":"10.1016\/j.mehy.2021.110645_b0335","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/WCO.0000000000000797","article-title":"Linking mechanisms of periodontitis to Alzheimer\u2019s disease","volume":"33","author":"Sadrameli","year":"2020","journal-title":"Curr opin Neurol"},{"issue":"1","key":"10.1016\/j.mehy.2021.110645_b0340","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3233\/JAD-200581","article-title":"Neurobiology of COVID-19","volume":"76","author":"Fotuhi","year":"2020","journal-title":"J Alzheimers Dis"},{"issue":"5","key":"10.1016\/j.mehy.2021.110645_b0345","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1007\/s12035-020-02236-2","article-title":"Pathophysiological clues to how the emergent SARS-CoV-2 can potentially increase the susceptibility to neurodegeneration","volume":"58","author":"Dolatshahi","year":"2021","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.mehy.2021.110645_b0350","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1016\/j.bbi.2020.10.019","article-title":"Cognitive disorders associated with hospitalization of COVID-19: Results from an observational cohort study","volume":"91","author":"Zhou","year":"2021","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.mehy.2021.110645_b0355","article-title":"SARS-COV-2 (COVID-19) has neurotropic and neuroinvasive properties","volume":"00","author":"Flores","year":"2020","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.mehy.2021.110645_b0360","doi-asserted-by":"crossref","unstructured":"Tremblay ME, Madore C, Bordeleau M, Tian L, Verkhratsky A. Neuropathobiology of COVID-19: The role for glia. Front Cell Neurosci 2020;14:592214. Published online 2020 Nov 11. 10.3389\/fncel.2020.592214.","DOI":"10.3389\/fncel.2020.592214"},{"issue":"3","key":"10.1016\/j.mehy.2021.110645_b0365","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41569-020-00469-1","article-title":"Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation","volume":"18","author":"Gu","year":"2021","journal-title":"Nat Rev Cardiol"},{"issue":"3","key":"10.1016\/j.mehy.2021.110645_b0370","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20201707","article-title":"Inflammasomes are activated in response to SARS-CoV-2 infection and are associated with COVID-19 severity in patients","volume":"218","author":"Rodrigues","year":"2021","journal-title":"J Exp Med"},{"key":"10.1016\/j.mehy.2021.110645_b0375","doi-asserted-by":"crossref","unstructured":"Goldstein MR, Poland GA, Graeber CW. Does apolipoprotein E genotype predict COVID-19 severity? QJM 2020;113:537-538. Published online 2020 Apr 27. 10.1093\/qjmed\/hcaa142.","DOI":"10.1093\/qjmed\/hcaa142"},{"issue":"11","key":"10.1016\/j.mehy.2021.110645_b0380","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1093\/gerona\/glaa131","article-title":"APOE e4 genotype predicts severe COVID-19 in the UK Biobank Community Cohort","volume":"75","author":"Kuo","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"issue":"6","key":"10.1016\/j.mehy.2021.110645_b0385","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1172\/JCI94494","article-title":"Sugar makes neutrophils RAGE: linking diabetes-associated hyperglycemia to thrombocytosis and platelet reactivity","volume":"127","author":"Lee","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/j.mehy.2021.110645_b0390","doi-asserted-by":"crossref","unstructured":"American Geriatrics Society 2019 updated AGS Beers criteria for potentially inappropriate medication use in older adults. By the 2019 American Geriatrics Society Beers Criteria\u00ae Update Expert Panel. J Am Geriatr Soc 2019;67(4):674-694. 10.1111\/jgs.15767.","DOI":"10.1111\/jgs.15767"},{"key":"10.1016\/j.mehy.2021.110645_b0395","doi-asserted-by":"crossref","unstructured":"Richardson K, Fox C, Maidment I, et al. Anticholinergic drugs and risk of dementia: case-control study. BMJ 2018;361:k1315. 101136\/bmj.k1315.","DOI":"10.1136\/bmj.k1315"},{"issue":"17","key":"10.1016\/j.mehy.2021.110645_b0400","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1908655","article-title":"For the PARAGON-HF investigators and committees","volume":"381","author":"Solomon","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.mehy.2021.110645_b0405","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrcardio.2016.200","article-title":"Long-term neprilysin inhibition \u2013 implications for ARNIs","volume":"14","author":"Campbell","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.mehy.2021.110645_b0410","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2020.111363","article-title":"Neprilysin expression and functions in development, ageing and disease","volume":"192","author":"Nalivaeva","year":"2020","journal-title":"Mech Ageing Dev"},{"issue":"19","key":"10.1016\/j.mehy.2021.110645_b0415","doi-asserted-by":"crossref","first-page":"7290","DOI":"10.3390\/ijms21197290","article-title":"Retinal degeneration and Alzheimer\u2019s disease: an evolving link","volume":"21","author":"Ashok","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.mehy.2021.110645_b0420","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1038\/mp.2016.251","article-title":"Beta-amyloid sequelae in the eye: a critical review on its diagnostic significance and clinical relevance in Alzheimer\u2019s disease","volume":"22","author":"Shah","year":"2017","journal-title":"Mol Psychiatry"},{"issue":"8","key":"10.1016\/j.mehy.2021.110645_b0425","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/eye.2015.100","article-title":"Dementia of the eye: the role of amyloid beta in retinal degeneration","volume":"29","author":"Ratnayaka","year":"2015","journal-title":"Eye (Lond)"},{"issue":"8","key":"10.1016\/j.mehy.2021.110645_b0430","first-page":"843","article-title":"Platelet-generated beta peptides in Alzheimer\u2019s disease and glaucoma","volume":"34","author":"Inyushin","year":"2019","journal-title":"Histol Histopathol"},{"issue":"9","key":"10.1016\/j.mehy.2021.110645_b0435","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/s41433-020-0836-x","article-title":"Neurodegeneration in Alzheimer\u2019s disease and glaucoma; overlaps and missing links","volume":"34","author":"Sen","year":"2020","journal-title":"Eye (Lond)"},{"key":"10.1016\/j.mehy.2021.110645_b0440","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.609765","article-title":"Ocular microbiota and intraocular inflammation","volume":"11","author":"Li","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.mehy.2021.110645_b0445","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.preteyeres.2018.01.001","article-title":"Epigenetics, microbiota, and intraocular inflammation: new paradigms of immune regulation in the eye","volume":"64","author":"Wen","year":"2018","journal-title":"Prog Retin Eye Res"},{"issue":"11","key":"10.1016\/j.mehy.2021.110645_b0450","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/s41582-018-0070-3","article-title":"Lifestyle interventions to prevent cognitive impairment, dementia and Alzheimer disease","volume":"14","author":"Kivipelto","year":"2018","journal-title":"Nat Rev Neurol"},{"issue":"10","key":"10.1016\/j.mehy.2021.110645_b0455","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jacc.2019.03.009","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"74","author":"Arnett","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"10.1016\/j.mehy.2021.110645_b0460","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/advances\/nmaa153","article-title":"Nut consumption for cognitive performance: A systematic review","volume":"12","author":"Theodore","year":"2021","journal-title":"Adv Nutr"},{"key":"10.1016\/j.mehy.2021.110645_b0465","doi-asserted-by":"crossref","DOI":"10.1016\/j.exger.2020.111145","article-title":"Physical activity in later life and risk of dementia: findings from a population-based cohort study","volume":"143","author":"Feter","year":"2021","journal-title":"Exp Gerontol"},{"issue":"9","key":"10.1016\/j.mehy.2021.110645_b0470","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S2213-8587(19)30076-2","article-title":"Understanding the mechanisms of reversal of type 2 diabetes","volume":"7","author":"Taylor","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.mehy.2021.110645_b0475","doi-asserted-by":"crossref","first-page":"738","DOI":"10.3389\/fphar.2019.00738","article-title":"Doxycycline for Alzheimer\u2019s disease; fighting \u00df-amyloid oligomers and neuroinflammation","volume":"10","author":"Balducci","year":"2019","journal-title":"Front Pharmacol"},{"issue":"10","key":"10.1016\/j.mehy.2021.110645_b0480","doi-asserted-by":"crossref","first-page":"669","DOI":"10.7326\/M19-3888","article-title":"Accuracy of biomarker testing for neuropathologically defined Alzheimer disease in older adults with dementia","volume":"172","author":"Fink","year":"2020","journal-title":"Ann Int Med"},{"issue":"17","key":"10.1016\/j.mehy.2021.110645_b0485","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma \u00df-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.mehy.2021.110645_b0490","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1001\/jama.2020.12134","article-title":"Discriminative accuracy of plasma phosphor-tau217 for Alzheimer disease vs other neurodegenerative disorders","volume":"324","author":"Palmqvist","year":"2020","journal-title":"JAMA"},{"issue":"11","key":"10.1016\/j.mehy.2021.110645_b0495","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/s41583-018-0067-3","article-title":"Imaging the evolution and pathophysiology of Alzheimer disease","volume":"19","author":"Jagust","year":"2018","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.mehy.2021.110645_b0500","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10465-016-9221-5","article-title":"Dance\/movement therapy and sensory stimulation: A holistic approach to dementia care","volume":"38","author":"Goldstein-Levitas","year":"2016","journal-title":"Am J Dance Ther"},{"issue":"1","key":"10.1016\/j.mehy.2021.110645_b0505","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.mayocp.2020.06.012","article-title":"Polypharmacy management in older patients","volume":"96","author":"Hoel","year":"2021","journal-title":"Mayo Clin Proc"}],"container-title":["Medical Hypotheses"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698772100164X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030698772100164X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T19:25:07Z","timestamp":1759692307000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030698772100164X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":101,"alternative-id":["S030698772100164X"],"URL":"https:\/\/doi.org\/10.1016\/j.mehy.2021.110645","relation":{},"ISSN":["0306-9877"],"issn-type":[{"value":"0306-9877","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"On the prevention and treatment of Alzheimer\u2019s disease: Control the promoters and look beyond the brain","name":"articletitle","label":"Article Title"},{"value":"Medical Hypotheses","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mehy.2021.110645","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"110645"}}